Leukapheresis
Leukapheresis is a specialized medical procedure designed to selectively remove white blood cells from a patient’s or donor’s blood. This technique is crucial for both therapeutic interventions and the collection of specific blood components for medical use.

Key Takeaways
- Leukapheresis is a medical procedure that selectively removes white blood cells (leukocytes) from a patient’s or donor’s blood.
- The process involves drawing blood, separating its components using an apheresis machine, and returning the remaining blood to the body.
- It is used therapeutically to treat conditions like hyperleukocytosis and for collecting white blood cells for stem cell transplantation or advanced immunotherapies.
- The procedure is generally safe but requires careful monitoring for potential side effects.
What is Leukapheresis?
Leukapheresis is a medical procedure that involves the selective removal of white blood cells (leukocytes) from a person’s blood. This process is typically performed using an apheresis machine, which separates blood components based on their density. The primary leukapheresis definition and purpose is to either reduce dangerously high levels of white blood cells in patients with certain conditions or to collect white blood cells from healthy donors for therapeutic use in others. It is a specialized form of apheresis, a broader category of procedures that separate blood components, focusing specifically on leukocytes.
The Leukapheresis Procedure Explained
The leukapheresis procedure explained involves a continuous blood flow through an apheresis machine. Patients or donors are connected to the machine via intravenous lines, usually in both arms. Blood is drawn from one arm, enters the machine, and is then processed. Inside the apheresis machine, centrifugal force is used to separate the blood into its various components: red blood cells, white blood cells, platelets, and plasma. The machine is programmed to specifically extract the white blood cells, while the remaining blood components are safely returned to the other arm. The entire process typically takes several hours, depending on the volume of blood to be processed and the specific goals of the procedure. Throughout the procedure, medical staff closely monitor the patient or donor for any adverse reactions, ensuring safety and efficacy.
Uses and Applications of Leukapheresis
The uses of leukapheresis are diverse, spanning both therapeutic interventions and donor collections. Therapeutically, it is primarily employed to manage conditions characterized by an excessive number of white blood cells, a state known as hyperleukocytosis. This can occur in certain types of leukemia, where the high white blood cell count can lead to complications such as impaired blood flow, respiratory distress, and neurological symptoms. By rapidly reducing the leukocyte count, leukapheresis can alleviate these acute symptoms and stabilize the patient’s condition, often as a bridge to definitive chemotherapy.
Another significant application is in the collection of hematopoietic stem cells for transplantation. In this context, leukapheresis is used to harvest stem cells, which are a type of white blood cell, from the peripheral blood of donors (either autologous, from the patient themselves, or allogeneic, from a compatible donor). These collected stem cells are then stored and later infused into a patient whose bone marrow has been compromised by disease or high-dose chemotherapy. According to the World Health Organization (WHO), hematopoietic stem cell transplantation is a critical treatment for various hematological malignancies and other disorders, with thousands of procedures performed globally each year, often relying on leukapheresis for cell collection.
Leukapheresis is also utilized for collecting specific types of white blood cells, such as lymphocytes, for advanced immunotherapies like CAR T-cell therapy, where a patient’s own T-cells are genetically modified to fight cancer. Furthermore, it can be used to collect granulocytes from healthy donors for transfusion into severely immunocompromised patients who have life-threatening infections and a deficiency in their own granulocytes.



















